140 related articles for article (PubMed ID: 12646024)
1. Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis.
Brenk R; Naerum L; Grädler U; Gerber HD; Garcia GA; Reuter K; Stubbs MT; Klebe G
J Med Chem; 2003 Mar; 46(7):1133-43. PubMed ID: 12646024
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening.
Brenk R; Meyer EA; Reuter K; Stubbs MT; Garcia GA; Diederich F; Klebe G
J Mol Biol; 2004 Apr; 338(1):55-75. PubMed ID: 15050823
[TBL] [Abstract][Full Text] [Related]
3. A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase.
Grädler U; Gerber HD; Goodenough-Lashua DM; Garcia GA; Ficner R; Reuter K; Stubbs MT; Klebe G
J Mol Biol; 2001 Feb; 306(3):455-67. PubMed ID: 11178905
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding.
Stengl B; Meyer EA; Heine A; Brenk R; Diederich F; Klebe G
J Mol Biol; 2007 Jul; 370(3):492-511. PubMed ID: 17524419
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis and crystallographic studies of Zymomonas mobilis tRNA-guanine transglycosylase reveal aspartate 102 as the active site nucleophile.
Romier C; Reuter K; Suck D; Ficner R
Biochemistry; 1996 Dec; 35(49):15734-9. PubMed ID: 8961936
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.
Ritschel T; Hoertner S; Heine A; Diederich F; Klebe G
Chembiochem; 2009 Mar; 10(4):716-27. PubMed ID: 19199329
[TBL] [Abstract][Full Text] [Related]
7. From lin-benzoguanines to lin-benzohypoxanthines as ligands for Zymomonas mobilis tRNA-guanine transglycosylase: replacement of protein-ligand hydrogen bonding by importing water clusters.
Barandun LJ; Immekus F; Kohler PC; Tonazzi S; Wagner B; Wendelspiess S; Ritschel T; Heine A; Kansy M; Klebe G; Diederich F
Chemistry; 2012 Jul; 18(30):9246-57. PubMed ID: 22736391
[TBL] [Abstract][Full Text] [Related]
8. Chemical trapping and crystal structure of a catalytic tRNA guanine transglycosylase covalent intermediate.
Xie W; Liu X; Huang RH
Nat Struct Biol; 2003 Oct; 10(10):781-8. PubMed ID: 12949492
[TBL] [Abstract][Full Text] [Related]
9. Flexible adaptations in the structure of the tRNA-modifying enzyme tRNA-guanine transglycosylase and their implications for substrate selectivity, reaction mechanism and structure-based drug design.
Brenk R; Stubbs MT; Heine A; Reuter K; Klebe G
Chembiochem; 2003 Oct; 4(10):1066-77. PubMed ID: 14523925
[TBL] [Abstract][Full Text] [Related]
10. Investigation of specificity determinants in bacterial tRNA-guanine transglycosylase reveals queuine, the substrate of its eucaryotic counterpart, as inhibitor.
Biela I; Tidten-Luksch N; Immekus F; Glinca S; Nguyen TX; Gerber HD; Heine A; Klebe G; Reuter K
PLoS One; 2013; 8(5):e64240. PubMed ID: 23704982
[TBL] [Abstract][Full Text] [Related]
11. How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase.
Ritschel T; Kohler PC; Neudert G; Heine A; Diederich F; Klebe G
ChemMedChem; 2009 Dec; 4(12):2012-23. PubMed ID: 19894214
[TBL] [Abstract][Full Text] [Related]
12. High-affinity inhibitors of Zymomonas mobilis tRNA-guanine transglycosylase through convergent optimization.
Barandun LJ; Immekus F; Kohler PC; Ritschel T; Heine A; Orlando P; Klebe G; Diederich F
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1798-807. PubMed ID: 23999303
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization.
Sanders WJ; Nienaber VL; Lerner CG; McCall JO; Merrick SM; Swanson SJ; Harlan JE; Stoll VS; Stamper GF; Betz SF; Condroski KR; Meadows RP; Severin JM; Walter KA; Magdalinos P; Jakob CG; Wagner R; Beutel BA
J Med Chem; 2004 Mar; 47(7):1709-18. PubMed ID: 15027862
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibitors of tRNA-guanine transglycosylase, an enzyme linked to the pathogenicity of the Shigella bacterium: charge-assisted hydrogen bonding.
Hörtner SR; Ritschel T; Stengl B; Kramer C; Schweizer WB; Wagner B; Kansy M; Klebe G; Diederich F
Angew Chem Int Ed Engl; 2007; 46(43):8266-9. PubMed ID: 17902085
[No Abstract] [Full Text] [Related]
15. An integrative approach combining noncovalent mass spectrometry, enzyme kinetics and X-ray crystallography to decipher Tgt protein-protein and protein-RNA interaction.
Ritschel T; Atmanene C; Reuter K; Van Dorsselaer A; Sanglier-Cianferani S; Klebe G
J Mol Biol; 2009 Nov; 393(4):833-47. PubMed ID: 19627989
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of tRNA-guanine transglycosylase: RNA modification by base exchange.
Romier C; Reuter K; Suck D; Ficner R
EMBO J; 1996 Jun; 15(11):2850-7. PubMed ID: 8654383
[TBL] [Abstract][Full Text] [Related]
17. High-affinity inhibitors of tRNA-guanine transglycosylase replacing the function of a structural water cluster.
Kohler PC; Ritschel T; Schweizer WB; Klebe G; Diederich F
Chemistry; 2009 Oct; 15(41):10809-17. PubMed ID: 19746363
[TBL] [Abstract][Full Text] [Related]
18. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
Deng Z; Chuaqui C; Singh J
J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
[TBL] [Abstract][Full Text] [Related]
19. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
Renner S; Schneider G
J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis and crystallographic studies of Zymomonas mobilis tRNA-guanine transglycosylase to elucidate the role of serine 103 for enzymatic activity.
Grädler U; Ficner R; Garcia GA; Stubbs MT; Klebe G; Reuter K
FEBS Lett; 1999 Jul; 454(1-2):142-6. PubMed ID: 10413112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
